To validate the call sets, the final list of TEAM somatic mutations was compared with three other publicly available breast cancer mutation sets (TGCA BRCA ER+ [42] and results published in [43]) to determine whether the somatic mutation frequency in each gene matched expectations. Here, ESR1 is linked to breast cancer.